Correction: SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes

doi:10.1038/s41420-021-00477-1

Published Erratum

. 2021 May 19;7(1):116.

doi: 10.1038/s41420-021-00477-1.

Correction: SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes

André C Ferreira^#^{1

2

3}, Vinicius Cardoso Soares^#^{4

5}, Isaclaudia G de Azevedo-Quintanilha⁴, Suelen da Silva Gomes Dias⁴, Natalia Fintelman-Rodrigues^{4

6}, Carolina Q Sacramento^{4

6}, Mayara Mattos^{4

6}, Caroline S de Freitas^{4

6}, Jairo R Temerozo^{7

8}, Lívia Teixeira⁴, Eugenio Damaceno Hottz^{4

9}, Ester A Barreto⁴, Camila R R Pão⁴, Lohanna Palhinha⁴, Milene Miranda¹⁰, Dumith Chequer Bou-Habib^{7

8}, Fernando A Bozza^{11

12}, Patrícia T Bozza⁴, Thiago Moreno L Souza^{13

14}

Affiliations

¹ Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, RJ, Brazil. tmoreno@cdts.fiocruz.br.
² Laboratório de Pesquisa Pré-clínica-Universidade Iguaçu - UNIG, Nova Iguaçu, RJ, Brazil. tmoreno@cdts.fiocruz.br.
³ National Institute for Science and Technology on Innovation in Diseases of Neglected Populations (INCT/IDPN), Center for Technological Development in Health (CDTS), Fiocruz, Rio de Janeiro, RJ, Brazil. tmoreno@cdts.fiocruz.br.
⁴ Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, RJ, Brazil.
⁵ Program of Immunology and Inflammation, Federal University of Rio de Janeiro, UFRJ, Rio de Janeiro, RJ, Brazil.
⁶ National Institute for Science and Technology on Innovation in Diseases of Neglected Populations (INCT/IDPN), Center for Technological Development in Health (CDTS), Fiocruz, Rio de Janeiro, RJ, Brazil.
⁷ Laboratório de Pesquisas sobre o Timo, IOC, Fiocruz, Rio de Janeiro, RJ, Brazil.
⁸ National Institute for Science and Technology on Neuroimmunomodulation, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro, RJ, Brazil.
⁹ Laboratório de Imunotrombose, Departamento de Bioquímica, Universidade Federal de Juiz de Fora, Juiz de Fora, MG, Brazil.
¹⁰ Laboratório de Vírus Respiratório e do Sarampo, IOC, Fiocruz, Rio de Janeiro, RJ, Brazil.
¹¹ Instituto Nacional de Infectologia Evandro Chagas, Fiocruz, Rio de Janeiro, RJ, Brazil.
¹² Instituto D'or de Pesquisa e Ensino, Rio de Janeiro, RJ, Brazil.
¹³ Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, RJ, Brazil. andre.bio2009@gmail.com.
¹⁴ National Institute for Science and Technology on Innovation in Diseases of Neglected Populations (INCT/IDPN), Center for Technological Development in Health (CDTS), Fiocruz, Rio de Janeiro, RJ, Brazil. andre.bio2009@gmail.com.

^# Contributed equally.

PMID: 34011951
PMCID: PMC8131489
DOI: 10.1038/s41420-021-00477-1

Free PMC article

Published Erratum

Correction: SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes

André C Ferreira et al. Cell Death Discov. 2021.

Free PMC article

. 2021 May 19;7(1):116.

doi: 10.1038/s41420-021-00477-1.

Authors

Affiliations

¹ Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, RJ, Brazil. tmoreno@cdts.fiocruz.br.
² Laboratório de Pesquisa Pré-clínica-Universidade Iguaçu - UNIG, Nova Iguaçu, RJ, Brazil. tmoreno@cdts.fiocruz.br.
³ National Institute for Science and Technology on Innovation in Diseases of Neglected Populations (INCT/IDPN), Center for Technological Development in Health (CDTS), Fiocruz, Rio de Janeiro, RJ, Brazil. tmoreno@cdts.fiocruz.br.
⁴ Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, RJ, Brazil.
⁵ Program of Immunology and Inflammation, Federal University of Rio de Janeiro, UFRJ, Rio de Janeiro, RJ, Brazil.
⁶ National Institute for Science and Technology on Innovation in Diseases of Neglected Populations (INCT/IDPN), Center for Technological Development in Health (CDTS), Fiocruz, Rio de Janeiro, RJ, Brazil.
⁷ Laboratório de Pesquisas sobre o Timo, IOC, Fiocruz, Rio de Janeiro, RJ, Brazil.
⁸ National Institute for Science and Technology on Neuroimmunomodulation, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro, RJ, Brazil.
⁹ Laboratório de Imunotrombose, Departamento de Bioquímica, Universidade Federal de Juiz de Fora, Juiz de Fora, MG, Brazil.
¹⁰ Laboratório de Vírus Respiratório e do Sarampo, IOC, Fiocruz, Rio de Janeiro, RJ, Brazil.
¹¹ Instituto Nacional de Infectologia Evandro Chagas, Fiocruz, Rio de Janeiro, RJ, Brazil.
¹² Instituto D'or de Pesquisa e Ensino, Rio de Janeiro, RJ, Brazil.
¹³ Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, RJ, Brazil. andre.bio2009@gmail.com.
¹⁴ National Institute for Science and Technology on Innovation in Diseases of Neglected Populations (INCT/IDPN), Center for Technological Development in Health (CDTS), Fiocruz, Rio de Janeiro, RJ, Brazil. andre.bio2009@gmail.com.

^# Contributed equally.

PMID: 34011951
PMCID: PMC8131489
DOI: 10.1038/s41420-021-00477-1

No abstract available

PubMed Disclaimer

Erratum for

SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes.
Ferreira AC, Soares VC, de Azevedo-Quintanilha IG, Dias SDSG, Fintelman-Rodrigues N, Sacramento CQ, Mattos M, de Freitas CS, Temerozo JR, Teixeira L, Damaceno Hottz E, Barreto EA, Pão CRR, Palhinha L, Miranda M, Bou-Habib DC, Bozza FA, Bozza PT, Souza TML. Ferreira AC, et al. Cell Death Discov. 2021 Mar 1;7(1):43. doi: 10.1038/s41420-021-00428-w. Cell Death Discov. 2021. PMID: 33649297 Free PMC article.

Cited by

The role of pyroptosis in viral infection.
Zhao Z, Zhang Y, Luo B. Zhao Z, et al. Arch Virol. 2024 Mar 8;169(3):69. doi: 10.1007/s00705-024-05978-9. Arch Virol. 2024. PMID: 38456965 Review.
Analysis of SARS-CoV-2 isolates, namely the Wuhan strain, Delta variant, and Omicron variant, identifies differential immune profiles.
Shahbaz S, Bozorgmehr N, Lu J, Osman M, Sligl W, Tyrrell DL, Elahi S. Shahbaz S, et al. Microbiol Spectr. 2023 Sep 7;11(5):e0125623. doi: 10.1128/spectrum.01256-23. Online ahead of print. Microbiol Spectr. 2023. PMID: 37676005 Free PMC article.
A comparison between SARS-CoV-1 and SARS-CoV2: an update on current COVID-19 vaccines.
Abdolmaleki G, Taheri MA, Paridehpour S, Mohammadi NM, Tabatabaei YA, Mousavi T, Amin M. Abdolmaleki G, et al. Daru. 2022 Dec;30(2):379-406. doi: 10.1007/s40199-022-00446-8. Epub 2022 Sep 2. Daru. 2022. PMID: 36050585 Free PMC article. Review.
Korean Red Ginseng, a regulator of NLRP3 inflammasome, in the COVID-19 pandemic.
Jung EM, Lee GS. Jung EM, et al. J Ginseng Res. 2022 May;46(3):331-336. doi: 10.1016/j.jgr.2022.02.003. Epub 2022 Feb 17. J Ginseng Res. 2022. PMID: 35194373 Free PMC article. Review.
Potential and Possible Therapeutic Effects of Melatonin on SARS-CoV-2 Infection.
Shchetinin E, Baturin V, Arushanyan E, Bolatchiev A, Bobryshev D. Shchetinin E, et al. Antioxidants (Basel). 2022 Jan 9;11(1):140. doi: 10.3390/antiox11010140. Antioxidants (Basel). 2022. PMID: 35052644 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Correction: SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes

Affiliations

Correction: SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes

Authors

Affiliations

Erratum for

Similar articles

Cited by

Publication types

LinkOut - more resources

Full Text Sources

Other Literature Sources

Miscellaneous